AtriCure (ATRC) Liabilities and Shareholders Equity (2010 - 2026)

AtriCure (ATRC) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $644.0 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 8.85% year-over-year to $644.0 million in Q1 2026; TTM through Mar 2026 was $2.5 billion, a 5.35% increase from a year earlier, with the FY2025 full-year figure at $654.2 million, up 7.36% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $644.0 million, down from $654.2 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for ATRC reached as high as $654.2 million in Q4 2025 and fell as low as $581.9 million in Q3 2022.
• Historically, Liabilities and Shareholders Equity has averaged $604.6 million across 5 years, with a median of $597.3 million in 2024.
• Across the five-year window, Liabilities and Shareholders Equity fell 16.42% in 2022 and rose 8.85% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $585.4 million in 2022, then increased by 4.87% to $613.9 million in 2023, then fell by 0.75% to $609.3 million in 2024, then increased by 7.36% to $654.2 million in 2025, then decreased by 1.56% to $644.0 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $644.0 million in Q1 2026, $654.2 million in Q4 2025, and $635.4 million in Q3 2025.